Cloud computing meets drug R&D

Drug makers are turning to Amazon, Google and Microsoft to adopt so-called cloud computing for their R&D efforts, with some noteworthy results, says Chemical & Engineering News. A recent article lists big guns Pfizer, Eli Lilly, Johnson & Johnson and Genentech among those accessing large storage and computing power across the Internet on a pay-as-you-go basis.

Among applications that have been tried successfully so far are scalable proteomics data processing, bioinformatics sequencing, and development of models for antibody docking runs, according to the article.

In cloud computing, big time savings and reasonable cost are balanced by issues of programming, compatibility and corporate security.

-read the article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.